BioNTech’s new plant to churn out 1 billion doses of COVID vaccine a year

MARBURG, Germany: Decontamination chambers, tight-fitting protective suits, a controlled atmosphere: Vigilance is the order of the day when making COVID-19 vaccines at the new BioNTech plant in Marburg, Germany.

From the outside, the facility is an unassuming building on the outskirts of the town north of Frankfurt in central Germany.

But that quickly changes when you step inside the rooms of the second European site to manufacture the vaccine developed by BioNTech with US giant Pfizer.